EdgarLookup

Unicycive Therapeutics, Inc. — All Filings

264 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 3 4 4/A 424B3 424B4 424B5 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT NT 10-Q POS AM PRE 14A S-1 S-1/A S-3 S-8 SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SC 13G SC 13G 0001104659-23-078756 Jul 6, 2023
8-K CURRENT REPORT 0001213900-23-053035 Jun 30, 2023 Jun 29, 2023
8-K CURRENT REPORT 0001213900-23-051702 Jun 26, 2023
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-23-048330 Jun 13, 2023
8-K CURRENT REPORT 0001213900-23-042369 May 23, 2023 May 17, 2023
8-K CURRENT REPORT 0001213900-23-040217 May 16, 2023
10-Q QUARTERLY REPORT 0001213900-23-040161 May 16, 2023 Mar 31, 2023
NT 10-Q NOTIFICATION OF LATE FILING 0001213900-23-040095 May 16, 2023 Mar 31, 2023
DEFA14A DEFA14A 0001213900-23-034012 May 1, 2023
ARS FORM ARS 0001213900-23-033858 Apr 28, 2023 Dec 31, 2022
DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-23-033853 Apr 28, 2023 Jun 26, 2023
4/A 0001213900-23-030791 Apr 18, 2023 Jul 15, 2022
PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-23-030746 Apr 18, 2023
8-K CURRENT REPORT 0001213900-23-028383 Apr 10, 2023 Apr 6, 2023
8-K CURRENT REPORT 0001213900-23-024969 Mar 31, 2023
10-K ANNUAL REPORT 0001213900-23-024901 Mar 31, 2023 Dec 31, 2022
8-K CURRENT REPORT 0001213900-23-024274 Mar 30, 2023 Mar 28, 2023
D 0001213900-23-019602 Mar 13, 2023
4 0001213900-23-018973 Mar 9, 2023 Mar 8, 2023
4 0001213900-23-018970 Mar 9, 2023 Mar 8, 2023
4 0001213900-23-018968 Mar 9, 2023 Mar 8, 2023
4 0001213900-23-018965 Mar 9, 2023 Mar 8, 2023
3 0001213900-23-018545 Mar 8, 2023
8-K CURRENT REPORT 0001213900-23-017841 Mar 6, 2023 Mar 3, 2023
8-K CURRENT REPORT 0001213900-23-016444 Mar 2, 2023 Feb 28, 2023
SC 13G/A SC 13G/A 0001104659-23-021860 Feb 14, 2023
SC 13G/A 0001172661-23-001191 Feb 14, 2023
8-K CURRENT REPORT 0001213900-23-008965 Feb 7, 2023 Feb 1, 2023
8-K CURRENT REPORT 0001213900-23-007404 Feb 2, 2023 Feb 1, 2023
8-K CURRENT REPORT 0001213900-22-083446 Dec 29, 2022
8-K CURRENT REPORT 0001213900-22-083051 Dec 28, 2022
4 0001213900-22-074723 Nov 23, 2022 Nov 21, 2022
4 0001213900-22-074722 Nov 23, 2022 Nov 21, 2022
4 0001213900-22-074721 Nov 23, 2022 Nov 21, 2022
4 0001213900-22-074724 Nov 23, 2022 Nov 21, 2022
3 OWNERSHIP DOCUMENT 0001213900-22-074030 Nov 21, 2022 Nov 18, 2022
8-K CURRENT REPORT 0001213900-22-071746 Nov 14, 2022
10-Q QUARTERLY REPORT 0001213900-22-071557 Nov 14, 2022 Sep 30, 2022
4 0001213900-22-052329 Aug 30, 2022 Jul 15, 2022
EFFECT 9999999995-22-002486 Aug 24, 2022
CORRESP 0001213900-22-050181 Aug 22, 2022
UPLOAD 0000000000-22-009031 Aug 22, 2022
S-3 REGISTRATION STATEMENT 0001213900-22-048239 Aug 16, 2022
8-K CURRENT REPORT 0001213900-22-048233 Aug 15, 2022
10-Q QUARTERLY REPORT 0001213900-22-048198 Aug 15, 2022 Jun 30, 2022
8-K CURRENT REPORT 0001213900-22-045405 Aug 8, 2022 Aug 2, 2022
8-K CURRENT REPORT 0001213900-22-039989 Jul 18, 2022 Jul 14, 2022
8-K CURRENT REPORT 0001213900-22-033329 Jun 16, 2022 Jun 15, 2022
4 0001213900-22-027501 May 17, 2022 May 16, 2022
8-K CURRENT REPORT 0001213900-22-025753 May 12, 2022